Redox vs Pfizer
Side-by-side comparison of AI visibility scores, market position, and capabilities
Redox processes 20M+ healthcare transactions/day and connects 75% of US health systems; strategic alliance with Kno2 in Oct 2025 creates a combined network transacting 40B+ annual transactions across 160,000 provider organizations.
About
Redox is a cloud-based healthcare data exchange and interoperability platform that enables digital health companies, health tech vendors, and healthcare organizations to connect and exchange clinical data across disparate EHR systems. Founded in 2014 and headquartered in Madison, Wisconsin, Redox standardizes healthcare data — translating between HL7 v2, FHIR, and proprietary EHR formats — and provides a single API integration layer that eliminates the need for vendors to build and maintain custom integrations with each health system they serve. The platform processes over 20 million transactions per day.
Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.
About
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.